Skip to content

Optimizing Strength Training in Older Adults

Optimizing Strength Training in Older Adults

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06812143
Acronym
LOAD
Enrollment
68
Registered
2025-02-06
Start date
2025-02-05
Completion date
2027-01-25
Last updated
2025-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Keywords

Strength training, Older adults, physical function

Brief summary

The objective of the current study is to determine whether lifting lighter loads close to failure improves strength training adaptations and function in older adults. The main questions it aims to answer are: 1. The effect of light loads on physical function 2. The effect of light loads on muscle mass, power, and strength Researchers will compare a light-load, high-repetition program to a standard strength training program. Participants will perform supervised strength training twice per week for 20 weeks.

Interventions

BEHAVIORALStrength training

This intervention involves strength training with lighter loads and higher repetitions.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
Queens College, The City University of New York
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Masking description

Statistician

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Males and females aged 65 years and above * Inactive lifestyle (\< 150 min per week of moderate intensity physical activity) and not regularly participating in a structured strength training program * Planning to reside in the area for the duration of the study

Exclusion criteria

* Severe cardiac disease, including Class III or IV congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest, use of a cardiac defibrillator, or uncontrolled angina * Lung disease requiring either oral or injected steroids, or the use of supplemental oxygen * Short, portable mental status questionnaire with 3 or more errors * Severe arthritis (either osteoarthritis or rheumatoid arthritis) * Cancer requiring treatment in the past 1 year (melanomas excluded) * Development of chest pain or severe shortness of breath during the 6 min self-paced walk test * Parkinson's disease or other serious neurological disorders * Renal disease requiring dialysis * Current diagnosis of schizophrenia, other psychotic disorders, or bipolar disorder * Current consumption of more than 14 alcoholic drinks per week * Severe lower back or shoulder pain that may worsen with weightlifting exercises * Undergoing physical therapy involving the lower extremities * Living in nursing homes, assisted living facilities or other similar institutions * Currently enrolled in another randomized trial involving a pharmaceutical or lifestyle intervention * Weight change (intentional or not) over the last 6 months of \> 5% of body weight, or plan to lose or gain weight during the study * Any other cardiovascular, pulmonary, orthopedic, neurologic, or other conditions that would preclude participation and successful completion of the protocol Temporary

Design outcomes

Primary

MeasureTime frameDescription
6-minute walk testBaseline and week 21Change in the total distance walked in 6 minutes. The 6-minute walk test is an objective, well-validated, and clinically meaningful measure of physical function in older adults.

Secondary

MeasureTime frameDescription
30-second chair stand testBaseline and week 21Change in the number of repetitions completed during the 30-Second chair stand test. This test assesses lower body functional strength and power.
Lower body maximal muscle strengthBaseline and week 21.Change in lower body maximum muscle strength will be assessed using a one-repetition maximum (1RM) test on a leg press machine.
Lower body muscle powerBaseline and week 21Lower body muscle peak power (W) will be assessed using a pneumatic leg press machine.
Lean body mass (LBM)Baseline and week 21Change in total lean body mass (kg) will be assessed using a dual-energy X-ray absorptiometry (DXA) scan
Get-up & go testBaseline and week 21Change in the time (in seconds) taken to complete the get up and go test. The get up & go test will be used to assess lower body dynamic balance and fall risk
Number of participants with adverse eventsFrom enrollment to the end of 20-week intervention periodNumber of participants experiencing adverse events that are possibly or definitely related to the intervention,
Physical activity enjoyment scale (PACES)Week 21Participants will complete the 18-item Physical activity enjoyment scale (PACES) to assess their level of physical activity enjoyment. Scores range from 18 to 126 and higher scores indicate greater enjoyment.
Exercise self-efficacy questionnaireWeek 21Participants will complete the exercise self-efficacy scale to assess their belief in their ability to continue strength training twice per week at the prescribed intensity in the future. Scores range from 0 to 100 and higher scores indicate greater self-efficacy.
Exercise session attendanceFrom enrollment to the end of 20-week intervention periodThe total number of supervised exercise sessions attended by participants over the 20-week intervention period.
Self-reported physical functionBaseline and week 21Self-reported physical function will be assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) physical function questionnaire. PROMIS measures are scored on the T-score metric. High scores mean more of the concept being measured.

Countries

United States

Contacts

Primary ContactAnoop T Balachandran, PhD
athozhuthungalba@qc.cuny.edu718-997-2729

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026